Ovarian cancer remains the deadliest gynecologic cancer. Although there are many subtypes of ovarian cancer, high-grade serous ovarian cancer accounts for more than 70% of ovarian cancer deaths, and overall survival has not changed significantly for several decades. An improved understanding of the precursor sites has allowed for new prevention strategies. Moreover, rapidly growing knowledge regarding the molecular and cellular features of ovarian cancer has resulted in new and effective therapeutic approaches.
|Title of host publication||Abeloff’s Clinical Oncology|
|State||Published - Jan 1 2019|
- Clinical diagnosis and management
- Ovarian cancer